The GR-1 is a general-purpose humanoid robot developed by Fourier Intelligence (China), standing 165 cm tall and weighing 55 kg with 40 degrees of freedom and a 50 kg payload capacity. It walks at up to 5 km/h using Fourier Smart Actuators (FSA) and features 6 RGB cameras providing 360-degree vision and a peak hip torque of 300 Nm. The GR-1 is designed for healthcare, industrial, and research applications, drawing on Fourier's expertise in medical exoskeleton technology. It has been deployed in Chinese Tier-1 hospitals and European automotive factories. Fourier Intelligence manufactures approximately 5,000 units annually and has since released successor models including the GR-3, a purpose-built care robot unveiled in August 2025.
Primary use case: General-purpose humanoid for healthcare assistance, hospital deployment, industrial automation, and embodied AI research — leveraging Fourier's medical exoskeleton expertise
Height
165 cm
Weight
55 kg
DOF
40
Payload
50 kg
Height
165 cm
Weight
55 kg
Degrees of Freedom
40
Locomotion
bipedal
Max Speed
5 km/h
Hand Type
5-finger dexterous
Payload
50 kg
Max Lift/Arm
3 kg
Autonomy Level
semi_autonomous
AI Capabilities
vision, speech, planning, manipulation, navigation
Onboard Compute
LLM-powered with emotional systems and high-resolution displays
Availability
Available
Primary Use Case
General-purpose humanoid for healthcare assistance, hospital deployment, industrial automation, and embodied AI research — leveraging Fourier's medical exoskeleton expertise
Our November 3 newsletter covers Meta and Fourier, factory robot trials, funding news and our interview with Lightberry’s CEO.
China's humanoid robot lead widens, with domestic vendors supplying over 95% of global shipments
Fourier Intelligence, a Chinese exoskeleton company, has pivoted to humanoid robotics with the GR-1, which claims to be China's fastest walking humanoid robot at 5 km/h. The company raised $170M in a Series B in 2023 and is targeting mass production of 100 robots in 2024 at $50,000-$70,000 per unit, focusing initially on healthcare assistance rather than industrial applications.